Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Sacubitril/valsartan for treating chronic heart failure with reduced ejection fraction
Drug guidance

Sacubitril/valsartan for treating chronic heart failure with reduced ejection fraction

Cardiovascular

4 January 2022

Guidance Recommendations

Subsidy status

Back to top